Repro Med Systems, Inc. provided revenue guidance for the fiscal year 2022. For fiscal year 2022, the Company expects revenue growth in the low to mid double digits, or $26.0 to $27.0 million on a full year basis.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.32 USD | -2.52% | +5.94% | -5.50% |
May. 01 | Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q1 Revenue $8.2M, vs. Street Est of $7.5M | MT |
May. 01 | Transcript : KORU Medical Systems, Inc., Q1 2024 Earnings Call, May 01, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.50% | 106M | |
-3.79% | 184B | |
-0.84% | 108B | |
-3.75% | 67.82B | |
+3.45% | 51.05B | |
+9.04% | 44.67B | |
+3.40% | 41.78B | |
+3.21% | 26.78B | |
+3.66% | 26.59B | |
+15.23% | 25.86B |
- Stock Market
- Equities
- KRMD Stock
- News KORU Medical Systems, Inc.
- Repro Med Systems, Inc. Provides Revenue Guidance for the Fiscal Year 2022